Companies: 10,795·Total market cap: $144.5T

Molecule Holdings Inc.

Molecule Holdings Inc.

EVRRFOTCHealthcare● Active

$0.00

+$0.00(+0.00%)

Market Cap$626130

P/E Ratio—

52W High$0.0025

52W Low$0.0025

Avg Volume11K

Open$0.00

Beta-0.45

Molecule Holdings Inc. (EVRRF) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

EVRRF · net income · updated Jun 9, 2026

Core profitability metrics

EVRRF · net income · margin · TTM · CAGR

Net income was −$4.5M for FY2022 (fiscal year ending 2022-10-31), down 7.5% year-over-year. Net profit margin was -230.8%.

FY2022 Net Income−$4.5M▼ -7.5% YoY

Trailing 12M (TTM)−$3.8Mtrailing 4 quarters sum

Net Profit Margin-230.8%−$4.5M ÷ $2.0M

YoY Change-7.5%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %

▸ FMP /income-statement · Annual · EVRRF net income history · EVRRF profit margin

Annual net income data

EVRRF · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2022Loss−$4.5M▼ 7.5%-230.8%$2.0M

FY2021Loss−$4.2M▼ 27.1%-928.6%$455,257

FY2020Loss−$3.3M▼ 204.9%—$0

FY2019Loss−$1.1M——$0

Net income vs peers (Healthcare)

EVRRF vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

#1

Molecule Holdings Inc.YOU

EVRRF

−$4.5M-7.5%-230.8%

Loss

Johnson & Johnson

$26.80B+90.6%28.5%

Eli Lilly and Company

$20.64B+94.9%31.7%

UnitedHealth Group Incorporated

$12.06B-16.3%2.7%

$4.23B-1.2%6.9%

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Molecule Holdings Inc. (EVRRF) reported net income of −$4.5M for FY2022 (fiscal year ending 2022-10-31), down 7.5% year-over-year. The net profit margin was -230.8% — meaning the company kept $-2.31 of every dollar of revenue as profit.

Molecule Holdings Inc. has not yet achieved annual profitability based on available data (4 fiscal years). The company has reported net losses across all available periods.

Molecule Holdings Inc.'s net profit margin was -230.8% for FY2022, based on the latest annual results.

Investors sometimes search for "Molecule Holdings Inc. net worth" — the company's market capitalization is a separate figure from EVRRF net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

EVRRF net income · 4 questions

Molecule Holdings Inc. is not currently profitable on an annual basis. The company reported a net loss of $4.5M for FY2022.

is EVRRF profitabledoes EVRRF make a profitEVRRF profitabilityEVRRF profitable company

▸ Source: FMP /income-statement · GAAP · Molecule Holdings Inc. · Molecule Holdings Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026